Plus therapeutics reports fourth quarter and full year 2020 financial results and business highlights

– positive interim data through cohort five for the respect™ phase 1 clinical trial in recurrent glioblastoma, announced november 2020 –

PSTV Ratings Summary

PSTV Quant Ranking